�UroToday.com - With advances in handling for prostate cancer and the oft deleterious side-effects of treatment, newly diagnosed men are faced with difficult intervention decisions. For men with localised disease, the complexity of treatment decision-making is enhanced by the whim that some tumours are indolent in nature and therefore unlikely to ever cause clinical concern or death if left untreated. As a result, many men experience high handling decision-related distress and for some hands this ass persist regular up to 12 months after discourse. Therefore, encouraging men to make informed treatment decisions is of primary pastime.
In Australia the specialiser nurse role has been identified in national genus Cancer strategy documents as a key scheme for facilitating psychosocial support and promoting adjustment for people stirred by cancer. We have therefore developed a conclusion support and psycho-education intervention utilising the prostate guardianship nurse model, ProsCan for Men. This intervention is the first support treatment to be trialled internationally that combines decision support with the specialist nurse model for prostate cancer patients.
ProsCan for Men utilises a tele-based method acting of obstetrical delivery to assure broader get hold of of the intervention undischarged to the geographical scattering of the Queensland population. Furthermore, the tele-based approaching provides greater potential for ProsCan for Men to translate into existing health services, such as Cancer Helplines.
Planning and ontogenesis of ProsCan for Men, including development of the Nurse Counsellor Manual and patient resources and pilotage, occurred over a 16 month period. Results from the pilot study have been encouraging. The pilot sample showed significant decreases in decisional conflict and intrusive thoughts (p
The randomised controlled tribulation (RCT) of ProsCan for Men has been afoot since September 2005. Three hundred and fifty work force per circumstance (700 work force in sum) have been recruited subsequently diagnosis and before intervention and randomised to 1) the tele-based nurse delivered five session decision support and psychosocial intervention or 2) common care. Recruitment required significant support from both clinicians in Queensland and the Urological Society of Australia and New Zealand. Data collection from the RCT will be completed in 2011. Multilevel modelling and growth mixture modelling will be applied to canvas longitudinal differences in final result. We look for that publications on the early results of the RCT will be available in 2009.
The undermentioned publications key ProsCan for Men in more contingent:
Chambers SK, Ferguson M, Gardiner RA, Nicol D, Gordon L, Occhipinti S, Aitken J. ProsCan for Men: Randomised controlled tribulation of a decision support intervention for men with localised prostate gland cancer. BMC Cancer 2008, 8:207.
Steginga SK, Ferguson M, Clutton S, Gardiner RA, Nicol D. Early decisiveness and psychosocial support interposition for manpower with localized prostate genus Cancer: an integrated approach. Supportive Care in Cancer 2008, 16:821-829.
ProsCan for Men is supported by grants from the Cancer Council Queensland and the National Health and Medical Research Council.
Our work in load-bearing men new diagnosed with prostate cancer has lED to the development of a sexuality support intervention for couples following surgery for prostate gland cancer, ProsCan for Couples. We testament be undertaking a RCT of ProsCan for Couples in 2008. The following publication describes the protocol for this study:
Chambers SK, Schover L, Halford K, Clutton S, Ferguson M, Gordon L, Gardiner RA, Occhipinti S, Dunn J. ProsCan for Couples: Randomised controlled trial of a couples-based sexuality intercession for workforce with localized prostate cancer who obtain radical prostatectomy. BMC Cancer 2008, 8:226.
Written by Megan Ferguson, MD, as function of Beyond the Abstract for UroToday.com
UroToday - the only urology website with original message written by global urology key belief leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to:
www.urotoday.com
Copyright � 2008 - UroToday
More info
